Alexandria Real Estate Equities Reports $3.74 Per-Share Loss, Adjusted FFO of $1.54
Alexandria Real Estate Equities reported a Q3 2026 net loss of $638.5M ($3.74 per share), including impairment charges. Adjusted FFO was $1.54 per share, down from $2.22 a year earlier. Revenue fell 10.7% YoY to $671.2M. The company narrowed its 2026 adjusted FFO guidance to $6.38–$6.42 per share. Occupancy was 87.1%, with leasing volume at 1.24M square feet.
How this was made

The 30-second read
Why it matters
The earnings miss and guidance cut are likely to depress the stock in the short term, but the company's strong leasing activity and asset sales may support a rebound.
Market read
The report provides fresh, material earnings data for a mid‑cap REIT, offering a clear trading signal.
What to watch
The sale of noncontrolling interest and new development projects could provide longer‑term upside not reflected in the immediate earnings reaction.
Background
Alexandria Real Estate Equities (ARE) is a specialty REIT focused on life science and office properties. The Q3 2026 results were released via an 8‑K filing.
Ticker impact
Q3 2026 earnings disclosed a $3.74 per-share loss and narrowed adjusted FFO guidance to $6.38‑$6.42, a fresh primary disclosure.
downward pressure as investors price in weaker earnings and reduced outlook
The company reported a large net loss and cut guidance, which historically leads to share declines for REITs.
Market effects
Highlights pressure on the REIT sector as earnings miss may prompt broader reassessment of office and biotech property valuations.
US real estate market sentiment could soften, affecting related REITs and property developers.
Limited to US real estate investors; minimal global macro impact.
Counterpoint
If the company’s occupancy and leasing momentum hold, the share price may be oversold, presenting a buying opportunity.
Key entities
- companyAlexandria Real Estate Equities
Specialty REIT reporting Q3 2026 earnings.

